The Centers for Disease Control and Prevention last week recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna’s updated COVID-19 vaccine booster for Americans aged 18 and older, as recommended by its vaccine advisory committee. Authorized by the Food and Drug Administration Aug. 31, the updated boosters are bivalent, meaning they help protect against the most recently circulating omicron variants as well as the original virus strain.  

“This recommendation followed a comprehensive scientific evaluation and robust scientific discussion,” said CDC Director Rochelle Walensky, M.D. “If you are eligible, there is no bad time to get your COVID-19 booster and I strongly encourage you to receive it.”

Related News Articles

Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National…
Headline
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-…